This study aimed to investigate the risks of bladder or rectal cancer for patients who have had surgery or external beam radiotherapy (EBRT) as a treatment for prostate cancer. This study found that radiation therapy led to a higher risk of bladder cancer, as compared to prostate surgery. 

This study aimed to examine the timing of exercise therapy in patients with prostate cancer taking androgen deprivation therapy (ADT). This study found that starting exercise at the onset of ADT helps preserve muscle mass and bone density. 

This study aimed to investigate the effect previous treatment has on overall survival for patients with metastatic (spread) prostate cancer. This study found that patients who had previous prostate surgery and radiation had improved overall survival. 

This study aimed to investigate the use of a surgical implant, in improving quality of life and side-effects of stress urinary incontinence after prostate cancer surgery. This study found that this implant led to significant improvements in quality of life in these patients.

This study looked at the effectiveness of chitosan membranes on sexual function after prostate tissue removal. It concluded that patients recovered sexual function quicker when they used chitosan. 

This study compared two types of radiation therapy in prostate cancer treatment. It concluded that brachytherapy (BT) is effective but may carry risks. 

This study investigated the effectiveness of prostate radiotherapy (RT) in prostate cancer (PC). They found that prostate RT may improve survival in men with PC and fewer than 5 bone metastasis (cancer that has spread to the bones). 

This study investigated whether adding apalutamide (erleada) to androgen-deprivation therapy (ADT) would improve survival in patients with prostate cancer. The authors concluded that adding apalutamide to ADT improved outcomes for these patients.

This study looked at the effect of curcumin on prostate cancer. It concluded that curcumin taken for 6 months was safe but did not reduce the need for hormone suppression therapy. 

This study aimed to investigate how effective high-intensity focused ultrasound (HIFU) is in the treatment of prostate cancer (PCa). This study found that HIFU is an effective option to treat PCa.